Your browser doesn't support javascript.
Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan.
Akiyama, Yutaro; Morioka, Shinichiro; Wakimoto, Yuji; Kawashima, Akira; Kanda, Kohei; Okuhama, Ayako; Suzuki, Tetsuya; Miyazato, Yusuke; Nomoto, Hidetoshi; Ide, Satoshi; Nakamoto, Takato; Nakamura, Keiji; Ota, Masayuki; Moriyama, Yuki; Takaya, Saho; Yamada, Kota; Taguchi, Maho; Sugito, Erika; Izuka, Shinji; Ishiguro, Kenji; Kobayashi, Toshiaki; Miyake, Wataru; Kubota, Shuji; Ishikane, Masahiro; Kinoshita, Noriko; Yamamoto, Kei; Ujiie, Mugen; Kutsuna, Satoshi; Hayakawa, Kayoko; Saito, Sho; Ohmagari, Norio.
  • Akiyama Y; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Morioka S; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Wakimoto Y; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Japan.
  • Kawashima A; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Kanda K; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Okuhama A; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Suzuki T; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Miyazato Y; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Nomoto H; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Japan.
  • Ide S; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Nakamoto T; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Nakamura K; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Japan.
  • Ota M; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Moriyama Y; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Japan.
  • Takaya S; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Yamada K; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Taguchi M; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Sugito E; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Izuka S; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Japan.
  • Ishiguro K; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Kobayashi T; Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Japan.
  • Miyake W; Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Japan.
  • Kubota S; Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Japan.
  • Ishikane M; Division of Rheumatic Diseases, National Center for Global Health and Medicine, Japan.
  • Kinoshita N; Division of Rheumatic Diseases, National Center for Global Health and Medicine, Japan.
  • Yamamoto K; Division of Rheumatic Diseases, National Center for Global Health and Medicine, Japan.
  • Ujiie M; Department of Cardiology, National Center for Global Health and Medicine, Japan.
  • Kutsuna S; Department of Cardiology, National Center for Global Health and Medicine, Japan.
  • Hayakawa K; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Saito S; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Ohmagari N; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Japan.
Intern Med ; 59(24): 3131-3133, 2020 Dec 15.
Article in English | MEDLINE | ID: covidwho-902226
ABSTRACT
Objective In fever clinics screening coronavirus disease (COVID-19), there could be patients with life-threatening diseases that physicians should not overlook. We exploratorily investigated the final diagnosis among non-COVID-19 hospitalized patients who visited the fever clinic. Methods This was a retrospective, observational, and single-centered study conducted in the National Center for Global Health and Medicine (NCGM), Tokyo, Japan. We conducted a retrospective chart review of patients who visited the fever clinic in the NCGM from 11 March 2020 to 24 April 2020. Patients Patients who met the following clinical criteria visited the fever clinic in the NCGM (1) body temperature >37.5°C, (2) any symptoms consistent with COVID-19 or (3) referral from local healthcare facilities. In the fever clinic, all patients who met the above criteria had severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test with nasopharyngeal swab specimens. Patients with severe symptoms or an unstable condition were sent to an outpatient clinic for infectious diseases for further evaluation and treatment. Results Among 1,470 patients who visited the fever clinic, 84 patients were hospitalized, and 45 of them were diagnosed as having COVID-19. Among the remaining 39 non-COVID-19 patients, there were nine patients with life-threatening diseases. The life-threatening diseases included acute heart failure, septic shock, pneumocystis pneumonia, peritonsillar abscess, and necrotizing fasciitis. Conclusion Physicians should evaluate each patient carefully while considering other life-threatening conditions even in such a COVID-19 pandemic era.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Viral / Pandemics / Fever / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Intern Med Journal subject: Internal Medicine Year: 2020 Document Type: Article Affiliation country: Internalmedicine.5614-20

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Viral / Pandemics / Fever / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Intern Med Journal subject: Internal Medicine Year: 2020 Document Type: Article Affiliation country: Internalmedicine.5614-20